Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases

NCT06542159 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Adaptive Radiotherapy
Stereotactic Body Radiotherapy
Non-small Cell Lung Cancer
Lung Oligometastases
Toxicity

Interventions

RADIATION: Online adaptive SBRT
RADIATION: Conventional SBRT

Sponsor

Sun Yat-sen University